FDA Approves Gemtuzumab Ozogamicin for CD-33 Positive Acute Myeloid Leukemia - Oncology Nurse AdvisorAcute Myeloid Leukemia Childhood Cancer Daily News Drug Information FDA Hematologic Cancers Monoclonal Antibody
